Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma | MicrobiomeTrials← Back to trialsNCT04069273
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2020-12-01Est. Completion: 2026-08-11
Enrollment target: 58 participants Locations- Mayo Clinic- Minnesota, Rochester, Minnesota, United States
- Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Other microbiome trials you might be interested in
HER2 Expressing Solid Tumors
This is a Phase 1/2, first-in-human, open-label, dose-escalating and expansion trial designed to assess the safety and e…
Los Angeles, United StatesEst. completion Sep 2033
Prostate CancerPesticide ExposuresLymphomaMultiple Myeloma
The "Agricultural Health Study" (AHS) is a collaborative effort between the National Cancer Institute and the National I…
Research Triangle Park, United States